Practice Management
Feature
Hypoxia-related discoveries net Nobel Prize
A trio of physician scientists have won the Nobel Prize for their work, which has implications for the treatment of anemia, cancer, and other...
From the Journals
Multigene testing for all patients with breast cancer may be cost-effective, life-saving
Modeling suggests high-risk multigene testing for all breast cancer patients might be cost-effective, but critics suggest “true costs are hidden...
Feature
Q&A: Drug costs and value in cancer
Dr. Richard L. Schilsky, chief medical officer at ASCO, tackles the issue of how to determine the value of cancer drugs.
Feature
Medical boards change or consider amending mental health-related licensing questions
Florida’s current medical licensing application may deter physicians from seeking care if they develop conditions such as depression, says Delicia...
From the Journals
Using reimbursement to drive innovation in tumor biomarker tests
Investigators propose a tiered, value-based reimbursement policy to help spur innovation and improve the clinical utility of tumor biomarker tests...
Law & Medicine
Labeling of medication warnings
Issuing timely warnings regarding medical products promotes patient safety, and the law appears to place the major onus on the manufacturer.
Latest News
Judge dismisses doctors’ lawsuit against ABIM
A court has thrown out a legal challenge levied by a group of physicians against the American Board of Internal Medicine over its maintenance of...
Conference Coverage
Patient-reported outcomes are here to stay
WASHINGTON – Despite growing interest in incorporating patient-reported outcomes into physician and hospital performance measures, officials are...
Feature
Legislators disagree on new drug-pricing proposal
New legislation by House Speaker Nancy Pelosi would require Medicare to negotiate drug prices with manufacturers.
Conference Coverage
CMS weighs extension of Oncology Care Model
WASHINGTON – An official with the Center for Medicare and Medicaid Innovation said the agency is hearing interest from physicians about continuing...
From the Journals
Physicians not yet comfortable with using social media to recruit for trials
In interviews, many physicians expressed interest but would like to have institutional support, guidelines, and training.